Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.44632809 |
2 | DNA deamination (GO:0045006) | 4.96647017 |
3 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.26680891 |
4 | ribosomal small subunit assembly (GO:0000028) | 4.17638174 |
5 | protein localization to endosome (GO:0036010) | 4.16916247 |
6 | protein targeting to ER (GO:0045047) | 4.15966766 |
7 | ribosomal small subunit biogenesis (GO:0042274) | 4.14052780 |
8 | cotranslational protein targeting to membrane (GO:0006613) | 4.12992979 |
9 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.09304122 |
10 | signal peptide processing (GO:0006465) | 4.02157623 |
11 | activation of Rac GTPase activity (GO:0032863) | 4.01459524 |
12 | COPI coating of Golgi vesicle (GO:0048205) | 3.99954161 |
13 | Golgi transport vesicle coating (GO:0048200) | 3.99954161 |
14 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.93222140 |
15 | protein localization to endoplasmic reticulum (GO:0070972) | 3.89204500 |
16 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.85933939 |
17 | regulation of early endosome to late endosome transport (GO:2000641) | 3.78216466 |
18 | mitochondrial DNA replication (GO:0006264) | 3.76495526 |
19 | pentose-phosphate shunt (GO:0006098) | 3.75344174 |
20 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.74267007 |
21 | maturation of SSU-rRNA (GO:0030490) | 3.73968335 |
22 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.69419799 |
23 | viral transcription (GO:0019083) | 3.67168014 |
24 | negative regulation of cell size (GO:0045792) | 3.67092453 |
25 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.59317738 |
26 | mitotic chromosome condensation (GO:0007076) | 3.53597346 |
27 | apoptotic process involved in morphogenesis (GO:0060561) | 3.52714741 |
28 | glucose catabolic process (GO:0006007) | 3.52354198 |
29 | regulation of translational fidelity (GO:0006450) | 3.50906741 |
30 | DNA unwinding involved in DNA replication (GO:0006268) | 3.48978749 |
31 | translational termination (GO:0006415) | 3.48337899 |
32 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.38945742 |
33 | ribosomal large subunit biogenesis (GO:0042273) | 3.36386217 |
34 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.34663508 |
35 | telomere maintenance via recombination (GO:0000722) | 3.31697839 |
36 | DNA-dependent DNA replication (GO:0006261) | 3.31242913 |
37 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.30849005 |
38 | glucose 6-phosphate metabolic process (GO:0051156) | 3.29849461 |
39 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.21865679 |
40 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.21865679 |
41 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.21720514 |
42 | histone H4-K12 acetylation (GO:0043983) | 3.18034002 |
43 | focal adhesion assembly (GO:0048041) | 3.17298360 |
44 | cell-substrate adherens junction assembly (GO:0007045) | 3.17298360 |
45 | NADPH regeneration (GO:0006740) | 3.16898661 |
46 | regulation of translational termination (GO:0006449) | 3.16418255 |
47 | maternal placenta development (GO:0001893) | 3.15603361 |
48 | pinocytosis (GO:0006907) | 3.13819513 |
49 | DNA replication checkpoint (GO:0000076) | 3.13390219 |
50 | adherens junction assembly (GO:0034333) | 3.11939062 |
51 | translational elongation (GO:0006414) | 3.11411790 |
52 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.08161751 |
53 | translation (GO:0006412) | 3.06828229 |
54 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.06794317 |
55 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.04756053 |
56 | RNA destabilization (GO:0050779) | 3.04092455 |
57 | cell-substrate junction assembly (GO:0007044) | 3.01676165 |
58 | protein retention in ER lumen (GO:0006621) | 3.00026474 |
59 | ribosome assembly (GO:0042255) | 2.99442314 |
60 | desmosome organization (GO:0002934) | 2.98531069 |
61 | hemidesmosome assembly (GO:0031581) | 2.96755364 |
62 | rRNA modification (GO:0000154) | 2.95684477 |
63 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.95160175 |
64 | germinal center formation (GO:0002467) | 2.93798358 |
65 | epithelial cell-cell adhesion (GO:0090136) | 2.92901221 |
66 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.90310772 |
67 | DNA strand elongation (GO:0022616) | 2.89779677 |
68 | translational initiation (GO:0006413) | 2.89444717 |
69 | GDP-mannose metabolic process (GO:0019673) | 2.87908421 |
70 | natural killer cell activation involved in immune response (GO:0002323) | 2.86126112 |
71 | mitotic recombination (GO:0006312) | 2.84925965 |
72 | modulation by symbiont of host cellular process (GO:0044068) | 2.84840107 |
73 | DNA damage response, detection of DNA damage (GO:0042769) | 2.82457649 |
74 | tRNA methylation (GO:0030488) | 2.81237968 |
75 | nuclear envelope reassembly (GO:0031468) | 2.80660884 |
76 | mitotic nuclear envelope reassembly (GO:0007084) | 2.80660884 |
77 | negative regulation of phagocytosis (GO:0050765) | 2.80482173 |
78 | cellular protein complex localization (GO:0034629) | 2.78349072 |
79 | valine metabolic process (GO:0006573) | 2.78217099 |
80 | regulation of antigen processing and presentation (GO:0002577) | 2.77560990 |
81 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.77483449 |
82 | RNA methylation (GO:0001510) | 2.77034067 |
83 | mitochondrial DNA metabolic process (GO:0032042) | 2.76765681 |
84 | negative regulation of fatty acid transport (GO:2000192) | 2.76647508 |
85 | telomere maintenance via telomere lengthening (GO:0010833) | 2.75618244 |
86 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.74904545 |
87 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.74875560 |
88 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.74249116 |
89 | glycolipid catabolic process (GO:0019377) | 2.73780429 |
90 | viral life cycle (GO:0019058) | 2.72336017 |
91 | proteasome assembly (GO:0043248) | 2.72018172 |
92 | mannose metabolic process (GO:0006013) | 2.70747135 |
93 | mRNA modification (GO:0016556) | 2.68777538 |
94 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.68732451 |
95 | negative regulation of viral release from host cell (GO:1902187) | 2.63453778 |
96 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.62364409 |
97 | DNA synthesis involved in DNA repair (GO:0000731) | 2.61338652 |
98 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.61305908 |
99 | sequestering of metal ion (GO:0051238) | 2.60782628 |
100 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.60775931 |
101 | DNA damage induced protein phosphorylation (GO:0006975) | 2.60716705 |
102 | ceramide catabolic process (GO:0046514) | 2.60191737 |
103 | endocrine pancreas development (GO:0031018) | 2.57975871 |
104 | stress fiber assembly (GO:0043149) | 2.57928987 |
105 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.57787237 |
106 | barbed-end actin filament capping (GO:0051016) | 2.57608601 |
107 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.56232957 |
108 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.56103002 |
109 | glycosphingolipid catabolic process (GO:0046479) | 2.54755923 |
110 | modulation by virus of host process (GO:0019054) | 2.53423594 |
111 | IMP biosynthetic process (GO:0006188) | 2.53024419 |
112 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.52632191 |
113 | protein targeting to membrane (GO:0006612) | 2.52315643 |
114 | pentose metabolic process (GO:0019321) | 2.52069608 |
115 | embryonic process involved in female pregnancy (GO:0060136) | 2.51236328 |
116 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.51102367 |
117 | termination of RNA polymerase III transcription (GO:0006386) | 2.51102367 |
118 | skin morphogenesis (GO:0043589) | 2.49681991 |
119 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.47951763 |
120 | DNA replication initiation (GO:0006270) | 2.47935151 |
121 | ER-nucleus signaling pathway (GO:0006984) | 2.47772055 |
122 | semaphorin-plexin signaling pathway (GO:0071526) | 2.47500766 |
123 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.46494009 |
124 | protein complex localization (GO:0031503) | 2.46094718 |
125 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.46000504 |
126 | nuclear pore complex assembly (GO:0051292) | 2.45443702 |
127 | regulation of histone H3-K27 methylation (GO:0061085) | 2.45051266 |
128 | formation of translation preinitiation complex (GO:0001731) | 2.44960806 |
129 | heterochromatin organization (GO:0070828) | 2.44635882 |
130 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.43450307 |
131 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.42852458 |
132 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.42068342 |
133 | cellular protein complex disassembly (GO:0043624) | 2.41034112 |
134 | positive regulation of nuclease activity (GO:0032075) | 2.40918468 |
135 | basement membrane organization (GO:0071711) | 2.40770933 |
136 | NIK/NF-kappaB signaling (GO:0038061) | 2.40436516 |
137 | amyloid precursor protein catabolic process (GO:0042987) | 2.40422844 |
138 | modulation by virus of host morphology or physiology (GO:0019048) | 2.39956219 |
139 | regulation of integrin activation (GO:0033623) | 2.39917945 |
140 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.39579055 |
141 | response to laminar fluid shear stress (GO:0034616) | 2.39513949 |
142 | regulation of mitochondrial translation (GO:0070129) | 2.39386523 |
143 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.39280453 |
144 | rRNA processing (GO:0006364) | 2.39045488 |
145 | protein localization to microtubule (GO:0035372) | 2.38861536 |
146 | pseudouridine synthesis (GO:0001522) | 2.38076013 |
147 | mRNA stabilization (GO:0048255) | 2.35820164 |
148 | RNA stabilization (GO:0043489) | 2.35820164 |
149 | activation of MAPKKK activity (GO:0000185) | 2.35581987 |
150 | positive regulation of histone deacetylation (GO:0031065) | 2.35349526 |
151 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.34968956 |
152 | UV protection (GO:0009650) | 2.34639695 |
153 | proline metabolic process (GO:0006560) | 2.33042215 |
154 | oligosaccharide catabolic process (GO:0009313) | 2.32588770 |
155 | protein maturation by protein folding (GO:0022417) | 2.32277333 |
156 | regulation of nuclease activity (GO:0032069) | 2.32122556 |
157 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.31858125 |
158 | regulation of superoxide anion generation (GO:0032928) | 2.31757356 |
159 | ribosome biogenesis (GO:0042254) | 2.31480109 |
160 | cellular response to unfolded protein (GO:0034620) | 2.31130691 |
161 | rRNA metabolic process (GO:0016072) | 2.30125671 |
162 | COPII vesicle coating (GO:0048208) | 2.30052210 |
163 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.29764461 |
164 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.29374573 |
165 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.28936410 |
166 | protein export from nucleus (GO:0006611) | 2.28793585 |
167 | exocrine pancreas development (GO:0031017) | 2.28594404 |
168 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.28095421 |
169 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.27209944 |
170 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.26506709 |
171 | folic acid metabolic process (GO:0046655) | 2.25810342 |
172 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.25744054 |
173 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.25439045 |
174 | regulation of chromatin binding (GO:0035561) | 2.23187133 |
175 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.22291119 |
176 | negative regulation of bone resorption (GO:0045779) | 2.22222452 |
177 | regulation of translation in response to stress (GO:0043555) | 2.22191960 |
178 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.21503819 |
179 | cellular component biogenesis (GO:0044085) | 2.20009226 |
180 | neutrophil mediated immunity (GO:0002446) | 2.19109669 |
181 | glandular epithelial cell differentiation (GO:0002067) | 2.18152749 |
182 | proline biosynthetic process (GO:0006561) | 2.17979241 |
183 | mRNA catabolic process (GO:0006402) | 2.17817805 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.00417069 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.41610969 |
3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.27181273 |
4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.18235504 |
5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.13923389 |
6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.04232332 |
7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.88556153 |
8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.82649310 |
9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.62939566 |
10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.57696440 |
11 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.41299838 |
12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.40141789 |
13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.38918436 |
14 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.34857830 |
15 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.31692723 |
16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.31264223 |
17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.28122211 |
18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.27355087 |
19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.23543649 |
20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.21627953 |
21 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.17969255 |
22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.10802572 |
23 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.09285553 |
24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.08211425 |
25 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.06142176 |
26 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.05770615 |
27 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.04530815 |
28 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.03275381 |
29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.00910694 |
30 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.99291220 |
31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.97351268 |
32 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.97303532 |
33 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.96559845 |
34 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94555208 |
35 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.92319068 |
36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90856543 |
37 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87924558 |
38 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80962101 |
39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.80621734 |
40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.74198000 |
41 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.71982070 |
42 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.71077956 |
43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.69856727 |
44 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.69558403 |
45 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.68956987 |
46 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.67201782 |
47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.66686282 |
48 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.64901744 |
49 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.64899027 |
50 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.64469910 |
51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.62038046 |
52 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.60829338 |
53 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.59925191 |
54 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57667621 |
55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.57635372 |
56 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.56422078 |
57 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.56317559 |
58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.55395546 |
59 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.54465386 |
60 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.54115124 |
61 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.53620145 |
62 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.53509069 |
63 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.53247027 |
64 | ATF3_27146783_Chip-Seq_COLON_Human | 1.51963509 |
65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51614787 |
66 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.50231690 |
67 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.49725768 |
68 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.49505778 |
69 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.46779395 |
70 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.46344470 |
71 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.46109162 |
72 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.45215285 |
73 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.43623743 |
74 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.40987510 |
75 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.40736961 |
76 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.40683877 |
77 | MYC_22102868_ChIP-Seq_BL_Human | 1.38094887 |
78 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37633559 |
79 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.37616209 |
80 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.36765205 |
81 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.35932554 |
82 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.35848227 |
83 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35417341 |
84 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.35232335 |
85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33974150 |
86 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.33690012 |
87 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.33522289 |
88 | KDM2B_26808549_Chip-Seq_K562_Human | 1.33385670 |
89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32024853 |
90 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.31057785 |
91 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.30242529 |
92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.30173157 |
93 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29554887 |
94 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.29107358 |
95 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.28603528 |
96 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.28347766 |
97 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27963405 |
98 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.27927232 |
99 | MYB_26560356_Chip-Seq_TH1_Human | 1.27757290 |
100 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.27747588 |
101 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27148365 |
102 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.26983123 |
103 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26652467 |
104 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26364123 |
105 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.26281085 |
106 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26185733 |
107 | * P68_20966046_ChIP-Seq_HELA_Human | 1.26022953 |
108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23799990 |
109 | MYB_26560356_Chip-Seq_TH2_Human | 1.23231593 |
110 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23218885 |
111 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.22432365 |
112 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.22043888 |
113 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.21493643 |
114 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.20168865 |
115 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.18537134 |
116 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.18273211 |
117 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.17845003 |
118 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17279936 |
119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.16816604 |
120 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16563353 |
121 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16358569 |
122 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.14298921 |
123 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13641585 |
124 | MAF_26560356_Chip-Seq_TH1_Human | 1.13324849 |
125 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.13185914 |
126 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.13183758 |
127 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.10509496 |
128 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.10468397 |
129 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.09212640 |
130 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.09109195 |
131 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.08451007 |
132 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08433762 |
133 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08327018 |
134 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.07993296 |
135 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07908829 |
136 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06866588 |
137 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.06558473 |
138 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.06314561 |
139 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05856260 |
140 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.05670565 |
141 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05445365 |
142 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05120261 |
143 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04707793 |
144 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04609449 |
145 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.04329479 |
146 | MAF_26560356_Chip-Seq_TH2_Human | 1.03151892 |
147 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03019026 |
148 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.02952364 |
149 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02835117 |
150 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02542536 |
151 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02539496 |
152 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.02193051 |
153 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01868101 |
154 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01580399 |
155 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.01359967 |
156 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00807332 |
157 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00789300 |
158 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.00122646 |
159 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99575495 |
160 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99227142 |
161 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98723587 |
162 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98682139 |
163 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98541335 |
164 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.98324994 |
165 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98053050 |
166 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.96352346 |
167 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.95854469 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003705_abnormal_hypodermis_morpholog | 4.43229270 |
2 | MP0005451_abnormal_body_composition | 3.70076943 |
3 | MP0010234_abnormal_vibrissa_follicle | 3.54993605 |
4 | MP0003693_abnormal_embryo_hatching | 2.86737747 |
5 | MP0005076_abnormal_cell_differentiation | 2.79507251 |
6 | MP0002877_abnormal_melanocyte_morpholog | 2.73758273 |
7 | MP0004185_abnormal_adipocyte_glucose | 2.57706669 |
8 | MP0001835_abnormal_antigen_presentation | 2.33711390 |
9 | MP0008057_abnormal_DNA_replication | 2.27019873 |
10 | MP0003453_abnormal_keratinocyte_physiol | 2.23169269 |
11 | MP0009840_abnormal_foam_cell | 2.22262137 |
12 | MP0002396_abnormal_hematopoietic_system | 2.15191352 |
13 | MP0003566_abnormal_cell_adhesion | 2.11103112 |
14 | MP0001849_ear_inflammation | 2.06255520 |
15 | MP0002693_abnormal_pancreas_physiology | 2.02897078 |
16 | MP0004858_abnormal_nervous_system | 1.93545171 |
17 | MP0008438_abnormal_cutaneous_collagen | 1.91096619 |
18 | MP0002796_impaired_skin_barrier | 1.88280199 |
19 | MP0003300_gastrointestinal_ulcer | 1.85586391 |
20 | MP0002138_abnormal_hepatobiliary_system | 1.84815841 |
21 | MP0000537_abnormal_urethra_morphology | 1.83298536 |
22 | MP0005220_abnormal_exocrine_pancreas | 1.83200096 |
23 | MP0004233_abnormal_muscle_weight | 1.81517763 |
24 | MP0003191_abnormal_cellular_cholesterol | 1.77793861 |
25 | MP0003436_decreased_susceptibility_to | 1.74926618 |
26 | MP0008260_abnormal_autophagy | 1.74691647 |
27 | MP0005670_abnormal_white_adipose | 1.74584277 |
28 | MP0003763_abnormal_thymus_physiology | 1.72905467 |
29 | MP0005501_abnormal_skin_physiology | 1.71119536 |
30 | MP0003111_abnormal_nucleus_morphology | 1.68443963 |
31 | MP0008007_abnormal_cellular_replicative | 1.65959385 |
32 | MP0001986_abnormal_taste_sensitivity | 1.57006207 |
33 | MP0005058_abnormal_lysosome_morphology | 1.55761858 |
34 | MP0005387_immune_system_phenotype | 1.52965827 |
35 | MP0001790_abnormal_immune_system | 1.52965827 |
36 | MP0002060_abnormal_skin_morphology | 1.51320271 |
37 | MP0004947_skin_inflammation | 1.51214807 |
38 | MP0001944_abnormal_pancreas_morphology | 1.50707129 |
39 | * MP0005000_abnormal_immune_tolerance | 1.50543228 |
40 | MP0001800_abnormal_humoral_immune | 1.48047029 |
41 | MP0005174_abnormal_tail_pigmentation | 1.47264366 |
42 | MP0003172_abnormal_lysosome_physiology | 1.46791516 |
43 | MP0005671_abnormal_response_to | 1.46680927 |
44 | MP0009278_abnormal_bone_marrow | 1.46029609 |
45 | MP0008058_abnormal_DNA_repair | 1.45150554 |
46 | MP0003091_abnormal_cell_migration | 1.44987310 |
47 | MP0005075_abnormal_melanosome_morpholog | 1.43548792 |
48 | MP0005025_abnormal_response_to | 1.43426354 |
49 | MP0003195_calcinosis | 1.42691262 |
50 | MP0000613_abnormal_salivary_gland | 1.41101551 |
51 | MP0004043_abnormal_pH_regulation | 1.40360792 |
52 | MP0009643_abnormal_urine_homeostasis | 1.39347424 |
53 | MP0000685_abnormal_immune_system | 1.39285034 |
54 | MP0000733_abnormal_muscle_development | 1.38875208 |
55 | MP0001730_embryonic_growth_arrest | 1.37694909 |
56 | MP0003077_abnormal_cell_cycle | 1.37551148 |
57 | MP0005464_abnormal_platelet_physiology | 1.36909562 |
58 | MP0004957_abnormal_blastocyst_morpholog | 1.36446968 |
59 | MP0005257_abnormal_intraocular_pressure | 1.34332828 |
60 | MP0009333_abnormal_splenocyte_physiolog | 1.33997949 |
61 | MP0002723_abnormal_immune_serum | 1.33941748 |
62 | * MP0002419_abnormal_innate_immunity | 1.32068553 |
63 | MP0000490_abnormal_crypts_of | 1.31557522 |
64 | MP0001666_abnormal_nutrient_absorption | 1.30608803 |
65 | * MP0002452_abnormal_antigen_presenting | 1.30427826 |
66 | MP0002166_altered_tumor_susceptibility | 1.29219967 |
67 | MP0005023_abnormal_wound_healing | 1.27542083 |
68 | * MP0002420_abnormal_adaptive_immunity | 1.27324657 |
69 | MP0005623_abnormal_meninges_morphology | 1.26263478 |
70 | MP0003186_abnormal_redox_activity | 1.26157024 |
71 | MP0001216_abnormal_epidermal_layer | 1.26028271 |
72 | * MP0001819_abnormal_immune_cell | 1.24721025 |
73 | MP0008469_abnormal_protein_level | 1.23618126 |
74 | MP0000689_abnormal_spleen_morphology | 1.22962175 |
75 | MP0005365_abnormal_bile_salt | 1.22955723 |
76 | MP0002148_abnormal_hypersensitivity_rea | 1.22180827 |
77 | MP0001348_abnormal_lacrimal_gland | 1.21297916 |
78 | MP0009785_altered_susceptibility_to | 1.21214393 |
79 | MP0005375_adipose_tissue_phenotype | 1.21204532 |
80 | MP0003868_abnormal_feces_composition | 1.20395125 |
81 | MP0000003_abnormal_adipose_tissue | 1.19066420 |
82 | MP0010155_abnormal_intestine_physiology | 1.18928119 |
83 | MP0002398_abnormal_bone_marrow | 1.18729873 |
84 | MP0000350_abnormal_cell_proliferation | 1.17714357 |
85 | MP0003724_increased_susceptibility_to | 1.17429915 |
86 | MP0005379_endocrine/exocrine_gland_phen | 1.16786392 |
87 | MP0000858_altered_metastatic_potential | 1.16048330 |
88 | MP0002876_abnormal_thyroid_physiology | 1.14953700 |
89 | MP0002722_abnormal_immune_system | 1.14337036 |
90 | MP0000566_synostosis | 1.13268482 |
91 | MP0000716_abnormal_immune_system | 1.12476898 |
92 | * MP0001845_abnormal_inflammatory_respons | 1.12311668 |
93 | MP0003866_abnormal_defecation | 1.12002552 |
94 | MP0002139_abnormal_hepatobiliary_system | 1.11031410 |
95 | MP0000678_abnormal_parathyroid_gland | 1.09859614 |
96 | MP0002249_abnormal_larynx_morphology | 1.08572497 |
97 | MP0005409_darkened_coat_color | 1.08078211 |
98 | MP0004381_abnormal_hair_follicle | 1.07307713 |
99 | MP0000371_diluted_coat_color | 1.06026804 |
100 | MP0000703_abnormal_thymus_morphology | 1.05369043 |
101 | MP0009053_abnormal_anal_canal | 1.04909213 |
102 | MP0000467_abnormal_esophagus_morphology | 1.04745757 |
103 | MP0010307_abnormal_tumor_latency | 1.04635500 |
104 | MP0003786_premature_aging | 1.03421585 |
105 | MP0010352_gastrointestinal_tract_polyps | 1.02971936 |
106 | MP0002277_abnormal_respiratory_mucosa | 1.02746747 |
107 | MP0002429_abnormal_blood_cell | 1.01395442 |
108 | MP0004808_abnormal_hematopoietic_stem | 1.00741321 |
109 | MP0002006_tumorigenesis | 0.99852873 |
110 | MP0004264_abnormal_extraembryonic_tissu | 0.99852075 |
111 | MP0010094_abnormal_chromosome_stability | 0.99751568 |
112 | MP0004510_myositis | 0.99050672 |
113 | MP0002080_prenatal_lethality | 0.98466804 |
114 | * MP0005621_abnormal_cell_physiology | 0.97491663 |
115 | MP0004272_abnormal_basement_membrane | 0.96478779 |
116 | MP0002098_abnormal_vibrissa_morphology | 0.94762876 |
117 | MP0001186_pigmentation_phenotype | 0.94546579 |
118 | MP0006036_abnormal_mitochondrial_physio | 0.94539577 |
119 | MP0003567_abnormal_fetal_cardiomyocyte | 0.93512800 |
120 | MP0002405_respiratory_system_inflammati | 0.93207564 |
121 | MP0002089_abnormal_postnatal_growth/wei | 0.93189170 |
122 | MP0009931_abnormal_skin_appearance | 0.92150530 |
123 | MP0003303_peritoneal_inflammation | 0.92036151 |
124 | MP0001661_extended_life_span | 0.91900586 |
125 | MP0002019_abnormal_tumor_incidence | 0.91420583 |
126 | MP0005408_hypopigmentation | 0.90536799 |
127 | MP0002086_abnormal_extraembryonic_tissu | 0.90500934 |
128 | MP0001764_abnormal_homeostasis | 0.90338820 |
129 | MP0003123_paternal_imprinting | 0.89241250 |
130 | MP0005389_reproductive_system_phenotype | 0.89191170 |
131 | MP0009379_abnormal_foot_pigmentation | 0.88805569 |
132 | MP0008932_abnormal_embryonic_tissue | 0.88453263 |
133 | MP0000465_gastrointestinal_hemorrhage | 0.87368898 |
134 | MP0002078_abnormal_glucose_homeostasis | 0.87069058 |
135 | MP0005332_abnormal_amino_acid | 0.86942789 |
136 | MP0001873_stomach_inflammation | 0.86711133 |
137 | MP0005310_abnormal_salivary_gland | 0.86689651 |
138 | MP0004782_abnormal_surfactant_physiolog | 0.86617840 |
139 | MP0002160_abnormal_reproductive_system | 0.85591504 |
140 | MP0002909_abnormal_adrenal_gland | 0.85320742 |
141 | MP0000609_abnormal_liver_physiology | 0.84364933 |
142 | MP0003828_pulmonary_edema | 0.84214678 |
143 | MP0000313_abnormal_cell_death | 0.84145092 |
144 | MP0003984_embryonic_growth_retardation | 0.83879408 |
145 | MP0003806_abnormal_nucleotide_metabolis | 0.83322159 |
146 | MP0006292_abnormal_olfactory_placode | 0.83283277 |
147 | MP0000015_abnormal_ear_pigmentation | 0.83261655 |
148 | MP0001672_abnormal_embryogenesis/_devel | 0.82576202 |
149 | MP0005380_embryogenesis_phenotype | 0.82576202 |
150 | MP0002998_abnormal_bone_remodeling | 0.82475723 |
151 | MP0009764_decreased_sensitivity_to | 0.81752272 |
152 | MP0000747_muscle_weakness | 0.81135365 |
153 | MP0003448_altered_tumor_morphology | 0.79280306 |
154 | MP0005666_abnormal_adipose_tissue | 0.78451697 |
155 | MP0005319_abnormal_enzyme/_coenzyme | 0.77633671 |
156 | MP0010771_integument_phenotype | 0.76581962 |
157 | MP0001756_abnormal_urination | 0.76229457 |
158 | MP0002088_abnormal_embryonic_growth/wei | 0.76119178 |
159 | MP0001919_abnormal_reproductive_system | 0.76032937 |
160 | MP0000759_abnormal_skeletal_muscle | 0.75537342 |
161 | MP0009672_abnormal_birth_weight | 0.75247534 |
162 | MP0000681_abnormal_thyroid_gland | 0.74322563 |
163 | MP0001697_abnormal_embryo_size | 0.73617004 |
164 | MP0000343_altered_response_to | 0.72819445 |
165 | MP0002896_abnormal_bone_mineralization | 0.71955818 |
166 | MP0002970_abnormal_white_adipose | 0.71495086 |
167 | * MP0005384_cellular_phenotype | 0.71235164 |
168 | MP0003075_altered_response_to | 0.70876028 |
169 | MP0010030_abnormal_orbit_morphology | 0.69654475 |
170 | MP0000627_abnormal_mammary_gland | 0.69508561 |
171 | MP0000750_abnormal_muscle_regeneration | 0.68099015 |
172 | MP0001881_abnormal_mammary_gland | 0.67978605 |
173 | MP0000762_abnormal_tongue_morphology | 0.67316015 |
174 | MP0000477_abnormal_intestine_morphology | 0.65737536 |
175 | MP0001915_intracranial_hemorrhage | 0.65697865 |
176 | MP0000579_abnormal_nail_morphology | 0.65678362 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Progressive external ophthalmoplegia (HP:0000590) | 4.15104115 |
2 | Hyperacusis (HP:0010780) | 3.69792650 |
3 | Proximal tubulopathy (HP:0000114) | 3.56567938 |
4 | Progressive muscle weakness (HP:0003323) | 3.42271838 |
5 | Hypoglycemic coma (HP:0001325) | 3.37868058 |
6 | Vertebral compression fractures (HP:0002953) | 3.35360826 |
7 | Type I transferrin isoform profile (HP:0003642) | 3.29656120 |
8 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.28846012 |
9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.28776447 |
10 | Achilles tendon contracture (HP:0001771) | 3.27729427 |
11 | Granulocytopenia (HP:0001913) | 3.23886501 |
12 | Distal lower limb amyotrophy (HP:0008944) | 3.13472240 |
13 | Broad face (HP:0000283) | 3.13077684 |
14 | IgM deficiency (HP:0002850) | 3.11618724 |
15 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.10570882 |
16 | Generalized aminoaciduria (HP:0002909) | 3.06172117 |
17 | Abnormality of T cell physiology (HP:0011840) | 2.98237788 |
18 | Abnormality of the Achilles tendon (HP:0005109) | 2.93441770 |
19 | Premature rupture of membranes (HP:0001788) | 2.90999954 |
20 | Reticulocytopenia (HP:0001896) | 2.89481362 |
21 | Aplastic anemia (HP:0001915) | 2.86698774 |
22 | Reduced antithrombin III activity (HP:0001976) | 2.85772599 |
23 | Ulnar bowing (HP:0003031) | 2.82340607 |
24 | Vacuolated lymphocytes (HP:0001922) | 2.78860627 |
25 | Abnormal number of erythroid precursors (HP:0012131) | 2.78297225 |
26 | Protrusio acetabuli (HP:0003179) | 2.77623462 |
27 | Abnormal glycosylation (HP:0012345) | 2.71577436 |
28 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.71577436 |
29 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.71577436 |
30 | Abnormal protein glycosylation (HP:0012346) | 2.71577436 |
31 | Short nail (HP:0001799) | 2.67860018 |
32 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.66081306 |
33 | Increased connective tissue (HP:0009025) | 2.64738619 |
34 | Thrombocytosis (HP:0001894) | 2.64347877 |
35 | Hypoglycemic seizures (HP:0002173) | 2.63286341 |
36 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.62281809 |
37 | Testicular atrophy (HP:0000029) | 2.62084251 |
38 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.62080241 |
39 | Abnormality of the common coagulation pathway (HP:0010990) | 2.46607883 |
40 | Upper limb amyotrophy (HP:0009129) | 2.43108339 |
41 | Distal upper limb amyotrophy (HP:0007149) | 2.43108339 |
42 | Trismus (HP:0000211) | 2.43036930 |
43 | Asymmetry of the thorax (HP:0001555) | 2.39581585 |
44 | Fragile skin (HP:0001030) | 2.38674759 |
45 | Late onset (HP:0003584) | 2.36487979 |
46 | Macrocytic anemia (HP:0001972) | 2.36361885 |
47 | Breast hypoplasia (HP:0003187) | 2.34407217 |
48 | Hepatic necrosis (HP:0002605) | 2.33244823 |
49 | Thin bony cortex (HP:0002753) | 2.32589625 |
50 | Flat acetabular roof (HP:0003180) | 2.32491284 |
51 | Symptomatic seizures (HP:0011145) | 2.29249915 |
52 | Distal lower limb muscle weakness (HP:0009053) | 2.28589872 |
53 | Eosinophilia (HP:0001880) | 2.27123302 |
54 | Abnormality of the intrinsic pathway (HP:0010989) | 2.26885195 |
55 | J-shaped sella turcica (HP:0002680) | 2.26849476 |
56 | Increased cerebral lipofuscin (HP:0011813) | 2.26810680 |
57 | Glucose intolerance (HP:0000833) | 2.20737029 |
58 | Cerebral aneurysm (HP:0004944) | 2.20512939 |
59 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.19794125 |
60 | Villous atrophy (HP:0011473) | 2.19794125 |
61 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.18788112 |
62 | Osteolytic defects of the hand bones (HP:0009699) | 2.18788112 |
63 | Inflammation of the large intestine (HP:0002037) | 2.18406902 |
64 | Unilateral renal agenesis (HP:0000122) | 2.17943490 |
65 | Long palpebral fissure (HP:0000637) | 2.16592659 |
66 | Abnormality of T cells (HP:0002843) | 2.15984908 |
67 | Disproportionate tall stature (HP:0001519) | 2.14859015 |
68 | Selective tooth agenesis (HP:0001592) | 2.13723644 |
69 | 11 pairs of ribs (HP:0000878) | 2.11625452 |
70 | Hyperparathyroidism (HP:0000843) | 2.11424203 |
71 | Chromsome breakage (HP:0040012) | 2.11082526 |
72 | Axonal loss (HP:0003447) | 2.10112128 |
73 | Cervical subluxation (HP:0003308) | 2.07616115 |
74 | Recurrent abscess formation (HP:0002722) | 2.07470490 |
75 | Birth length less than 3rd percentile (HP:0003561) | 2.07209778 |
76 | Insomnia (HP:0100785) | 2.07090631 |
77 | Petechiae (HP:0000967) | 2.07009654 |
78 | Elbow flexion contracture (HP:0002987) | 2.05374229 |
79 | Hyperglycemia (HP:0003074) | 2.04613924 |
80 | Gastrointestinal inflammation (HP:0004386) | 2.02825335 |
81 | Micronodular cirrhosis (HP:0001413) | 2.02486058 |
82 | Patellar dislocation (HP:0002999) | 2.02456672 |
83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.01343451 |
84 | Dysostosis multiplex (HP:0000943) | 2.01051564 |
85 | Abnormality of macrophages (HP:0004311) | 2.01011524 |
86 | Abnormality of the umbilical cord (HP:0010881) | 2.00674496 |
87 | Prolonged bleeding time (HP:0003010) | 1.99700061 |
88 | Large for gestational age (HP:0001520) | 1.98698538 |
89 | Broad distal phalanx of finger (HP:0009836) | 1.98622280 |
90 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.98459170 |
91 | Hemorrhage of the eye (HP:0011885) | 1.96544946 |
92 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.95004886 |
93 | Generalized amyotrophy (HP:0003700) | 1.94914836 |
94 | Exertional dyspnea (HP:0002875) | 1.94334331 |
95 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.93680413 |
96 | Abnormality of the thoracic spine (HP:0100711) | 1.93580879 |
97 | Eczematoid dermatitis (HP:0000976) | 1.93489609 |
98 | Ragged-red muscle fibers (HP:0003200) | 1.93226491 |
99 | Meningitis (HP:0001287) | 1.92445858 |
100 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.91533689 |
101 | Lower limb amyotrophy (HP:0007210) | 1.91063493 |
102 | Abnormality of oral frenula (HP:0000190) | 1.90404065 |
103 | Mitral regurgitation (HP:0001653) | 1.90387511 |
104 | Stridor (HP:0010307) | 1.89969422 |
105 | Premature skin wrinkling (HP:0100678) | 1.89624808 |
106 | Ankyloglossia (HP:0010296) | 1.88419978 |
107 | Spinal cord compression (HP:0002176) | 1.87756910 |
108 | Stomach cancer (HP:0012126) | 1.87756397 |
109 | Syringomyelia (HP:0003396) | 1.87222577 |
110 | Spinal cord lesions (HP:0100561) | 1.87222577 |
111 | Microretrognathia (HP:0000308) | 1.86825667 |
112 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.86604487 |
113 | Hypertensive crisis (HP:0100735) | 1.86133859 |
114 | Nuclear cataract (HP:0100018) | 1.84247792 |
115 | Hypokinesia (HP:0002375) | 1.83539395 |
116 | Difficulty climbing stairs (HP:0003551) | 1.82946711 |
117 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.82854682 |
118 | Decreased circulating renin level (HP:0003351) | 1.82470128 |
119 | Recurrent bacterial skin infections (HP:0005406) | 1.82427359 |
120 | Spinal rigidity (HP:0003306) | 1.81387633 |
121 | Microvesicular hepatic steatosis (HP:0001414) | 1.80880879 |
122 | Pallor (HP:0000980) | 1.80708071 |
123 | Septate vagina (HP:0001153) | 1.79858609 |
124 | Bone pain (HP:0002653) | 1.79522372 |
125 | Pancytopenia (HP:0001876) | 1.78913669 |
126 | Advanced eruption of teeth (HP:0006288) | 1.78635798 |
127 | Reticulocytosis (HP:0001923) | 1.78615194 |
128 | Myositis (HP:0100614) | 1.78608935 |
129 | Sparse lateral eyebrow (HP:0005338) | 1.78453884 |
130 | Colitis (HP:0002583) | 1.77961193 |
131 | Myocardial infarction (HP:0001658) | 1.77958643 |
132 | Abnormality of the renal collecting system (HP:0004742) | 1.77783546 |
133 | Periodontitis (HP:0000704) | 1.77637453 |
134 | Multiple enchondromatosis (HP:0005701) | 1.77019005 |
135 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.76989152 |
136 | Carpal bone hypoplasia (HP:0001498) | 1.76917803 |
137 | Chronic obstructive pulmonary disease (HP:0006510) | 1.75574322 |
138 | Obstructive lung disease (HP:0006536) | 1.75574322 |
139 | Abnormal ossification of hand bones (HP:0005921) | 1.75352764 |
140 | Conjugated hyperbilirubinemia (HP:0002908) | 1.75348413 |
141 | Blue sclerae (HP:0000592) | 1.75180487 |
142 | Recurrent viral infections (HP:0004429) | 1.74961634 |
143 | Rough bone trabeculation (HP:0100670) | 1.74936469 |
144 | Abnormality of the tricuspid valve (HP:0001702) | 1.74898668 |
145 | Cholecystitis (HP:0001082) | 1.74323796 |
146 | Abnormal gallbladder physiology (HP:0012438) | 1.74323796 |
147 | Natal tooth (HP:0000695) | 1.74244466 |
148 | Pustule (HP:0200039) | 1.73718274 |
149 | Prominent metopic ridge (HP:0005487) | 1.73331098 |
150 | Progressive neurologic deterioration (HP:0002344) | 1.73256467 |
151 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.73145703 |
152 | Duplicated collecting system (HP:0000081) | 1.72573333 |
153 | Subacute progressive viral hepatitis (HP:0006572) | 1.72414449 |
154 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.72103621 |
155 | Insulin resistance (HP:0000855) | 1.71651932 |
156 | Joint hemorrhage (HP:0005261) | 1.71600856 |
157 | Encephalitis (HP:0002383) | 1.71570982 |
158 | Ankle contracture (HP:0006466) | 1.70638476 |
159 | Cheilitis (HP:0100825) | 1.70534495 |
160 | Deviation of the thumb (HP:0009603) | 1.70305944 |
161 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.69999698 |
162 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.69999698 |
163 | Abnormality of glycolipid metabolism (HP:0010969) | 1.69999698 |
164 | Back pain (HP:0003418) | 1.69954312 |
165 | Abnormality of carpal bone ossification (HP:0006257) | 1.69359864 |
166 | Ketoacidosis (HP:0001993) | 1.69286961 |
167 | IgA deficiency (HP:0002720) | 1.69084600 |
168 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.68515181 |
169 | Mucopolysacchariduria (HP:0008155) | 1.68515181 |
170 | Interstitial pulmonary disease (HP:0006530) | 1.68331609 |
171 | Nausea (HP:0002018) | 1.68230587 |
172 | Bone marrow hypocellularity (HP:0005528) | 1.68092603 |
173 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.67980867 |
174 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.67611070 |
175 | Agammaglobulinemia (HP:0004432) | 1.67581782 |
176 | Abdominal distention (HP:0003270) | 1.67498610 |
177 | Renal cortical cysts (HP:0000803) | 1.67223808 |
178 | Hepatocellular necrosis (HP:0001404) | 1.67112726 |
179 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.66766600 |
180 | Recurrent cutaneous fungal infections (HP:0011370) | 1.66766600 |
181 | Ridged nail (HP:0001807) | 1.66363467 |
182 | Loss of speech (HP:0002371) | 1.65402422 |
183 | Bowed forearm bones (HP:0003956) | 1.63733102 |
184 | Bowing of the arm (HP:0006488) | 1.63733102 |
185 | Fatigue (HP:0012378) | 1.63251041 |
186 | Truncus arteriosus (HP:0001660) | 1.60352713 |
187 | Atrophic scars (HP:0001075) | 1.60311566 |
188 | Easy fatigability (HP:0003388) | 1.59884688 |
189 | Deep venous thrombosis (HP:0002625) | 1.59180495 |
190 | Multiple lipomas (HP:0001012) | 1.58398201 |
191 | Cerebral inclusion bodies (HP:0100314) | 1.57800496 |
192 | Cellulitis (HP:0100658) | 1.57444043 |
193 | Hyperthyroidism (HP:0000836) | 1.56978734 |
194 | Thoracic kyphosis (HP:0002942) | 1.56055574 |
195 | Congenital glaucoma (HP:0001087) | 1.56020349 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SMG1 | 3.70524486 |
2 | PLK4 | 3.54015247 |
3 | ZAK | 3.44335991 |
4 | MST1R | 2.93746729 |
5 | EIF2AK3 | 2.79015593 |
6 | STK16 | 2.75026140 |
7 | TAOK3 | 2.72253311 |
8 | PRPF4B | 2.70097799 |
9 | ICK | 2.65962856 |
10 | EEF2K | 2.58323188 |
11 | BUB1 | 2.39626969 |
12 | ERN1 | 2.28825687 |
13 | MAP4K1 | 2.10323950 |
14 | INSRR | 2.03654943 |
15 | BCKDK | 2.02910077 |
16 | FLT3 | 1.98689745 |
17 | TTN | 1.96611600 |
18 | NME2 | 1.83640454 |
19 | PASK | 1.78442627 |
20 | CDK12 | 1.76873949 |
21 | TAOK2 | 1.69868700 |
22 | BLK | 1.69397206 |
23 | NLK | 1.67082467 |
24 | WEE1 | 1.61748204 |
25 | * IRAK4 | 1.57334674 |
26 | TEC | 1.55922898 |
27 | EPHA2 | 1.54978707 |
28 | SCYL2 | 1.52265069 |
29 | TYK2 | 1.50414402 |
30 | SRPK1 | 1.48802033 |
31 | TTK | 1.48521496 |
32 | JAK3 | 1.47224462 |
33 | BTK | 1.44979381 |
34 | ARAF | 1.44020458 |
35 | EIF2AK1 | 1.43456982 |
36 | MAP2K3 | 1.41717523 |
37 | BRSK2 | 1.38871639 |
38 | TESK1 | 1.38212204 |
39 | HIPK2 | 1.36783630 |
40 | PDGFRA | 1.35921454 |
41 | LMTK2 | 1.31762054 |
42 | RIPK1 | 1.30474657 |
43 | IKBKB | 1.27049397 |
44 | MET | 1.27016171 |
45 | ZAP70 | 1.20474465 |
46 | TAOK1 | 1.20098957 |
47 | DYRK3 | 1.20084924 |
48 | NEK9 | 1.19459557 |
49 | KIT | 1.17626972 |
50 | PTK2 | 1.16519587 |
51 | KDR | 1.15254977 |
52 | RPS6KA4 | 1.13729040 |
53 | MTOR | 1.09328216 |
54 | TESK2 | 1.09104168 |
55 | MAP3K14 | 1.08297979 |
56 | TSSK6 | 1.06241152 |
57 | TLK1 | 1.01236881 |
58 | PRKD3 | 0.99145118 |
59 | CDK8 | 0.97842476 |
60 | LRRK2 | 0.97698047 |
61 | PIK3CG | 0.97681839 |
62 | ILK | 0.97523664 |
63 | VRK1 | 0.97494817 |
64 | MAP3K13 | 0.95803137 |
65 | BRAF | 0.94455758 |
66 | RPS6KB2 | 0.92121857 |
67 | IKBKE | 0.92062975 |
68 | ATR | 0.91194111 |
69 | CHUK | 0.90977041 |
70 | CDC42BPA | 0.88884768 |
71 | CAMK1D | 0.88228358 |
72 | FRK | 0.87348148 |
73 | MAPK11 | 0.86899866 |
74 | JAK1 | 0.86219280 |
75 | KSR2 | 0.85709265 |
76 | PDPK1 | 0.84748087 |
77 | EPHA3 | 0.84380465 |
78 | STK10 | 0.84306030 |
79 | LATS2 | 0.84192662 |
80 | CDK4 | 0.82587803 |
81 | MAPK15 | 0.81867016 |
82 | BMX | 0.81852135 |
83 | MOS | 0.76816467 |
84 | PAK4 | 0.76547312 |
85 | TRIB3 | 0.75837961 |
86 | FGFR4 | 0.74150640 |
87 | MARK1 | 0.73444217 |
88 | PIM1 | 0.70802105 |
89 | MAPKAPK3 | 0.70736813 |
90 | TIE1 | 0.70734104 |
91 | TBK1 | 0.70273302 |
92 | EPHB1 | 0.70061119 |
93 | CLK1 | 0.70018844 |
94 | ABL2 | 0.69912442 |
95 | MAP2K2 | 0.69856484 |
96 | CSF1R | 0.69268393 |
97 | PIM2 | 0.68903066 |
98 | VRK2 | 0.68252675 |
99 | MAP3K3 | 0.67913339 |
100 | TGFBR2 | 0.65150054 |
101 | TXK | 0.64955903 |
102 | STK4 | 0.64331513 |
103 | MKNK2 | 0.64131183 |
104 | CSK | 0.63610794 |
105 | RPS6KA2 | 0.63336372 |
106 | DDR2 | 0.63286424 |
107 | PLK1 | 0.63239171 |
108 | PRKD2 | 0.63159570 |
109 | MAP3K11 | 0.62396672 |
110 | AURKB | 0.60853775 |
111 | SIK3 | 0.60136725 |
112 | ERBB4 | 0.59821971 |
113 | LCK | 0.58117885 |
114 | PKN2 | 0.58083046 |
115 | PRKG2 | 0.57881166 |
116 | AKT3 | 0.56829198 |
117 | STK38L | 0.56614794 |
118 | CDK7 | 0.56080558 |
119 | PTK6 | 0.56033075 |
120 | LYN | 0.55982641 |
121 | AURKA | 0.55038952 |
122 | NME1 | 0.54817215 |
123 | JAK2 | 0.54350189 |
124 | RPS6KC1 | 0.53853026 |
125 | RPS6KL1 | 0.53853026 |
126 | SYK | 0.53510831 |
127 | MAP3K8 | 0.53167267 |
128 | CHEK2 | 0.53010264 |
129 | MAP3K9 | 0.52808734 |
130 | * IRAK3 | 0.52690817 |
131 | PAK2 | 0.52374750 |
132 | STK24 | 0.52016671 |
133 | CDK6 | 0.52014708 |
134 | ITK | 0.51439611 |
135 | MARK2 | 0.51317451 |
136 | EIF2AK2 | 0.50615648 |
137 | MAP3K10 | 0.49899160 |
138 | BRD4 | 0.49749790 |
139 | NUAK1 | 0.48565637 |
140 | MAPKAPK2 | 0.47549372 |
141 | CDK9 | 0.46635436 |
142 | NTRK1 | 0.46267153 |
143 | TNK2 | 0.45796288 |
144 | CAMK1G | 0.45689309 |
145 | MAPK4 | 0.45372851 |
146 | SIK1 | 0.45288469 |
147 | MAPK7 | 0.44903053 |
148 | AKT2 | 0.42466146 |
149 | MELK | 0.42232789 |
150 | ATM | 0.42014669 |
151 | CSNK2A1 | 0.41920832 |
152 | MAP3K1 | 0.41309432 |
153 | MAP3K2 | 0.38395811 |
154 | DAPK1 | 0.36870096 |
155 | EPHB2 | 0.36696950 |
156 | LIMK1 | 0.36623949 |
157 | PAK1 | 0.36072739 |
158 | PBK | 0.36024451 |
159 | CHEK1 | 0.35927476 |
160 | BRSK1 | 0.35092604 |
161 | PDK1 | 0.34918430 |
162 | RPS6KA6 | 0.33145849 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protein export_Homo sapiens_hsa03060 | 4.43707815 |
2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.99687068 |
3 | Ribosome_Homo sapiens_hsa03010 | 3.42203640 |
4 | DNA replication_Homo sapiens_hsa03030 | 3.19752474 |
5 | RNA polymerase_Homo sapiens_hsa03020 | 2.45677622 |
6 | Bladder cancer_Homo sapiens_hsa05219 | 2.42445500 |
7 | Mismatch repair_Homo sapiens_hsa03430 | 2.35731513 |
8 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.35288619 |
9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.30041457 |
10 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.18546856 |
11 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.15325779 |
12 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 2.03071378 |
13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.98330129 |
14 | Proteasome_Homo sapiens_hsa03050 | 1.91237676 |
15 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.89772984 |
16 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.87642203 |
17 | Homologous recombination_Homo sapiens_hsa03440 | 1.83557050 |
18 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.80652977 |
19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.72175456 |
20 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.71790613 |
21 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.64287284 |
22 | Spliceosome_Homo sapiens_hsa03040 | 1.62701924 |
23 | Base excision repair_Homo sapiens_hsa03410 | 1.60210385 |
24 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.56446521 |
25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.53152263 |
26 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.51106382 |
27 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.51088790 |
28 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.49866247 |
29 | Prion diseases_Homo sapiens_hsa05020 | 1.44806774 |
30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44470612 |
31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.42248741 |
32 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.41154101 |
33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.39729294 |
34 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.37862622 |
35 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.35978028 |
36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.33823005 |
37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.28825583 |
38 | Endometrial cancer_Homo sapiens_hsa05213 | 1.27640986 |
39 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.27336769 |
40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.25547417 |
41 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.22804175 |
42 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.21392537 |
43 | Glioma_Homo sapiens_hsa05214 | 1.20327631 |
44 | Shigellosis_Homo sapiens_hsa05131 | 1.20150660 |
45 | RNA transport_Homo sapiens_hsa03013 | 1.16502893 |
46 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.15332929 |
47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.15013818 |
48 | Hepatitis B_Homo sapiens_hsa05161 | 1.13652433 |
49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.13261059 |
50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.11340987 |
51 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.10540890 |
52 | RNA degradation_Homo sapiens_hsa03018 | 1.09701700 |
53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.08516329 |
54 | Salmonella infection_Homo sapiens_hsa05132 | 1.06393975 |
55 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06084624 |
56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.05359526 |
57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00870121 |
58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00612385 |
59 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.00301500 |
60 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.00071700 |
61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99680856 |
62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98811971 |
63 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.98052021 |
64 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.96142650 |
65 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.96043096 |
66 | Focal adhesion_Homo sapiens_hsa04510 | 0.95159251 |
67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.92971508 |
68 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92294281 |
69 | Purine metabolism_Homo sapiens_hsa00230 | 0.90682812 |
70 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.89948382 |
71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.89404831 |
72 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.88085609 |
73 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.87859829 |
74 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.87260281 |
75 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86970392 |
76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86638795 |
77 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85897771 |
78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84830888 |
79 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84810014 |
80 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83797212 |
81 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83624438 |
82 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83362757 |
83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83344641 |
84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83137815 |
85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82976331 |
86 | Lysosome_Homo sapiens_hsa04142 | 0.82962901 |
87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82938726 |
88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82518891 |
89 | * Measles_Homo sapiens_hsa05162 | 0.81655887 |
90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80333876 |
91 | Cell cycle_Homo sapiens_hsa04110 | 0.77132470 |
92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77074867 |
93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76359419 |
94 | Amoebiasis_Homo sapiens_hsa05146 | 0.75831728 |
95 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73868971 |
96 | Insulin resistance_Homo sapiens_hsa04931 | 0.73585237 |
97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73381456 |
98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72969388 |
99 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72480492 |
100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72415154 |
101 | Basal transcription factors_Homo sapiens_hsa03022 | 0.69711262 |
102 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69163694 |
103 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68806015 |
104 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68786568 |
105 | * Toxoplasmosis_Homo sapiens_hsa05145 | 0.67895702 |
106 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67589622 |
107 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.67497419 |
108 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67062214 |
109 | Melanoma_Homo sapiens_hsa05218 | 0.66892155 |
110 | Endocytosis_Homo sapiens_hsa04144 | 0.66854085 |
111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66376930 |
112 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66074067 |
113 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65087279 |
114 | * Leishmaniasis_Homo sapiens_hsa05140 | 0.64466627 |
115 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62652847 |
116 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62486900 |
117 | Peroxisome_Homo sapiens_hsa04146 | 0.62365565 |
118 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.60049304 |
119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59993271 |
120 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58996874 |
121 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.58740508 |
122 | ABC transporters_Homo sapiens_hsa02010 | 0.58119712 |
123 | Legionellosis_Homo sapiens_hsa05134 | 0.57553171 |
124 | Lysine degradation_Homo sapiens_hsa00310 | 0.56983147 |
125 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.56974786 |
126 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56949915 |
127 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.56559538 |
128 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.56521308 |
129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55937554 |
130 | Parkinsons disease_Homo sapiens_hsa05012 | 0.55063116 |
131 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.54995633 |
132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54356889 |
133 | Adherens junction_Homo sapiens_hsa04520 | 0.53384326 |
134 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52832167 |
135 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51376225 |
136 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.50993964 |
137 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50671319 |
138 | Apoptosis_Homo sapiens_hsa04210 | 0.50447286 |
139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49546572 |
140 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49043882 |
141 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.48547035 |
142 | Influenza A_Homo sapiens_hsa05164 | 0.48064750 |
143 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47993788 |
144 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47110365 |
145 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46713154 |
146 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45187206 |
147 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43759200 |
148 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43702599 |
149 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42875935 |
150 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.42078249 |
151 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40932661 |
152 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39553938 |
153 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39277763 |
154 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37948700 |
155 | Prostate cancer_Homo sapiens_hsa05215 | 0.36990051 |
156 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.36168157 |
157 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.36047540 |
158 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35496803 |
159 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35474993 |
160 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.35259978 |
161 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34936823 |
162 | Hepatitis C_Homo sapiens_hsa05160 | 0.34223201 |
163 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32251546 |